市场调查报告书
商品编码
1608895
医疗检体追踪系统市场:按产品、按技术、按最终用户、按地区Medical Specimen Tracking System Market, By Product, By Technology (Barcode Systems, Radio Frequency Identification, and Others), By End User, By Geography |
医疗检体追踪系统市场预计到 2024 年将达到 8.349 亿美元,预计到 2031 年将达到 17.115 亿美元,2024 年至 2031 年的复合年增长率为 10.8%。
报告范围 | 报告详情 | ||
---|---|---|---|
基准年 | 2023年 | 2024年市场规模 | 8.349 亿美元 |
实际资料 | 2019-2023 | 预测期 | 2024年至2031年 |
预测 2024-2031 年复合年增长率: | 10.80% | 2031年价值预测 | 17.115 亿美元 |
近年来,由于整个医疗机构对敏感医疗检体的高效运输和管理的需求不断增加,医疗检体追踪系统市场经历了显着增长。随着诊断测试的数量和复杂性的增加,检体运输和处理对于按时提供可靠的测试结果起着至关重要的作用。医学检体追踪使医院和实验室能够有效地追踪检体从采集到分析的整个过程,并在各个阶段接收警报。这有助于确保安全、课责和准确的诊断结果。检体追踪解决方案提供检体移动的即时可见性,降低检体错误识别或遗失的风险。随着对优质医疗服务的需求不断增加,医疗检体追踪系统预计将在未来几年成为实验室工作流程管理的重要组成部分。
全球医学检体追踪系统市场的推动因素包括诊断测试日益复杂、对高效实验室管理系统的需求以及有关实验室检体处理的严格法规等。然而,实施和维护追踪系统的高昂成本限制了市场的成长。技术的进步正在为创新提供机会,而区块链和人工智慧驱动的解决方案可能会塑造未来的市场。使用无线射频识别 (RFID) 和物联网进行即时检体追踪可实现实验室内的高效工作负载分配和工作流程自动化,从而提高生产力。监管机构对检体监管链控制的严格要求也推动了采用。然而,与这些先进解决方案相关的高额前期投资和维护成本继续限制了成本敏感地区的市场渗透。
该报告对全球医学检体追踪系统市场进行了详细分析,并提供了以2023年为基准年的预测期(2024-2031)的市场规模和年复合成长率(CAGR%)。
它揭示了各个细分市场的潜在商机,并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
根据公司亮点、产品系列、主要亮点、绩效和策略等参数,包括全球医疗检体追踪系统市场的主要企业概况。
本研究涵盖的主要企业包括 RMS Omega、Peak Technologies、GAO RFID Inc.、Cryoport System LLC、LabConnect、F. Hoffmann-La Roche Ltd、NovoPath、STARLIMS Corporation、LabWare 和 BioIT Solutions, Inc.。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球医学检体追踪系统市场报告针对该行业的各个相关人员,如投资者、供应商、产品製造商、经销商、新进入者和财务分析师。
透过用于分析全球医学检体追踪系统市场的各种策略矩阵,将促进相关人员的决策。
The medical specimen tracking system market is estimated to be valued at USD 834.9 Mn in 2024 and is expected to reach USD 1,711.5 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.8% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | 834.9 Mn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
Forecast Period 2024 to 2031 CAGR: | 10.80% | 2031 Value Projection: | 1,711.5 Mn |
The medical specimen tracking system market has seen significant growth in recent years owing to the growing need for efficient transportation and management of sensitive medical specimens across healthcare facilities. As the volume and complexity of diagnostic testing has increased, transportation and handling of specimens play a critical role in delivering reliable test results on time. Medical specimen tracking allows hospitals and laboratories to efficiently track specimens from collection to analysis and receive alerts at various stages. This ensures safety, accountability and aids in obtaining accurate diagnostic outcomes. Medical specimen tracking solutions provide real-time visibility into specimen movement, reducing the risk of misidentification or loss of samples. With increasing demand for quality healthcare services, medical specimen tracking systems are expected to become an integral part of laboratory workflow management in the coming years.
The global medical specimen tracking system market is driven by factors such as growing complexity of diagnostic testing, need for efficient laboratory management systems, and stringent regulations regarding lab specimen handling. However, high costs of implementation and maintenance of tracking systems pose a restraint to market growth. Advancement of technology is opening up opportunities for innovation, with Blockchain and AI enabled solutions likely to shape the future market. Real time specimen tracking using Radio-Frequency Identification (RFID) and IoT enables efficient workload distribution and workflow automation within labs, increasing productivity. Stringent requirements by regulatory bodies regarding chain of custody management of specimens are also boosting adoption. However, high upfront investment and maintenance costs associated with these advanced solutions continue to limit market penetration in cost sensitive regions.
This report provides in-depth analysis of the global medical specimen tracking system market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global medical specimen tracking system market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include RMS Omega, Peak Technologies, GAO RFID Inc., Cryoport System LLC, LabConnect, F. Hoffmann-La Roche Ltd, NovoPath, STARLIMS Corporation, LabWare, and BioIT Solutions, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global medical specimen tracking system market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical specimen tracking system market